Stephen J Hoffman - Net Worth and Insider Trading
Stephen J Hoffman Net Worth
The estimated net worth of Stephen J Hoffman is at least $4,688 dollars as of 2024-11-13. Stephen J Hoffman is the CEO of Aerpio Pharmaceuticals Inc and owns about 2,131 shares of Aerpio Pharmaceuticals Inc (ARPO) stock worth over $4,688. Stephen J Hoffman is also the Director of Genocea Biosciences Inc and owns about 249,052 shares of Genocea Biosciences Inc (GNCAQ) stock worth over $0. Details can be seen in Stephen J Hoffman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Stephen J Hoffman has not made any transactions after 2018-11-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Stephen J Hoffman
Stephen J Hoffman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Stephen J Hoffman owns 8 companies in total, including Talphera Inc (TLPH) , Dicerna Pharmaceuticals Inc (DRNA) , and Aerpio Pharmaceuticals Inc (ARPO) among others .
Click here to see the complete history of Stephen J Hoffman’s form 4 insider trades.
Insider Ownership Summary of Stephen J Hoffman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TLPH | Talphera Inc | 2012-05-29 | director & 10 percent owner |
| DRNA | Dicerna Pharmaceuticals Inc | 2020-06-15 | director |
| ARPO | Aerpio Pharmaceuticals Inc | 2019-05-14 | director & Chief Executive Officer |
 | | 2015-03-17 | director |
| | 2014-03-12 | 10 percent owner |
| | 2017-12-01 | Chief Executive Officer |
| | 2021-03-17 | director |
| | 2015-02-26 | director |
Stephen J Hoffman Latest Holdings Summary
Stephen J Hoffman currently owns a total of 2 stocks. Among these stocks, Stephen J Hoffman owns 2,131 shares of Aerpio Pharmaceuticals Inc (ARPO) as of November 12, 2018, with a value of $4,688 and a weighting of 100%. Stephen J Hoffman also owns 249,052 shares of Genocea Biosciences Inc (GNCAQ) as of March 17, 2015, with a value of $0 and a weighting of 0%.
Latest Holdings of Stephen J Hoffman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ARPO | Aerpio Pharmaceuticals Inc | 2018-11-12 | 2,131 | 2.20 | 4,688 |
| GNCAQ | Genocea Biosciences Inc | 2015-03-17 | 249,052 | 0.00 | 0 |
Holding Weightings of Stephen J Hoffman
Stephen J Hoffman Form 4 Trading Tracker
According to the SEC Form 4 filings, Stephen J Hoffman has made a total of 0 transactions in Aerpio Pharmaceuticals Inc (ARPO) over the past 5 years. The most-recent trade in Aerpio Pharmaceuticals Inc is the acquisition of 2,131 shares on November 12, 2018, which cost Stephen J Hoffman around $64,254.
According to the SEC Form 4 filings, Stephen J Hoffman has made a total of 0 transactions in Genocea Biosciences Inc (GNCAQ) over the past 5 years. The most-recent trade in Genocea Biosciences Inc is the acquisition of 87,500 shares on March 17, 2015, which cost Stephen J Hoffman around $6 Million.
Insider Trading History of Stephen J Hoffman
- 1
Stephen J Hoffman Trading Performance
GuruFocus tracks the stock performance after each of Stephen J Hoffman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Stephen J Hoffman is 56.56%. GuruFocus also compares Stephen J Hoffman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Stephen J Hoffman within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Stephen J Hoffman's insider trading performs compared to the benchmark.
Performance of Stephen J Hoffman
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 19.49 | | | | | |
| Relative Return to S&P 500(%) | 20.71 | | | | | |
Stephen J Hoffman Ownership Network
Ownership Network List of Stephen J Hoffman
Ownership Network Relation of Stephen J Hoffman
Stephen J Hoffman Owned Company Details
What does Talphera Inc do?
Who are the key executives at Talphera Inc?
Stephen J Hoffman is the director & 10 percent owner of Talphera Inc. Other key executives at Talphera Inc include director & Chief Executive Officer Vincent J. Angotti , director & Chief Medical Officer Pamela P Palmer , and Chief Engineering Officer Badri N Dasu .
Talphera Inc (TLPH) Insider Trades Summary
Over the past 18 months, Stephen J Hoffman made no insider transaction in Talphera Inc (TLPH). Other recent insider transactions involving Talphera Inc (TLPH) include a net purchase of 37,260 shares made by Vincent J. Angotti , and a net sale of 16,956 shares made by Pamela P Palmer .
In summary, during the past 3 months, insiders sold 0 shares of Talphera Inc (TLPH) in total and bought 7,260 shares, with a net purchase of 7,260 shares. During the past 18 months, 16,956 shares of Talphera Inc (TLPH) were sold and 37,260 shares were bought by its insiders, resulting in a net purchase of 20,304 shares.
Talphera Inc (TLPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Talphera Inc Insider Transactions
Stephen J Hoffman Mailing Address
Above is the net worth, insider trading, and ownership report for Stephen J Hoffman. You might contact Stephen J Hoffman via mailing address: C/o Skyline Ventures, 525 University Ave., Suite 1350, Palo Alto Ca 94301.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
